Beijing SL Pharmaceutical Co., Ltd.
Simbol: 002038.SZ
SHZ
8.62
CNYPrețul de piață astăzi
31.0841
Raportul P/E
2.4867
Raportul PEG
8.86B
MRK Cap
- 0.01%
Randament DIV
Beijing SL Pharmaceutical Co., Ltd. (002038-SZ) Situații financiare
Bilanț
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 5056.78 | 2133 | 739.9 | 990.2 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 2289.51 | 1449.2 | 144.9 | 162.4 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 1134.59 | 236.2 | 406.4 | 534 | |||||||||||||||||||||||
balance-sheet.row.inventory | 625.05 | 144.5 | 136.8 | 124.8 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 2585.99 | 126.3 | 714.5 | 648.7 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 9402.41 | 2640 | 1997.7 | 2297.7 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 2044.8 | 538.4 | 527.3 | 604 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 4425.3 | 1143.7 | 978.5 | 872.8 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 4425.3 | 1143.7 | 978.5 | 872.8 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 5601.25 | 1587.3 | 1295.1 | 1241.3 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 77.69 | 0 | 39.5 | 27.7 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 3192.71 | 368.4 | 1037.7 | 717 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 15341.75 | 3637.8 | 3878.2 | 3462.7 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 24744.16 | 6277.8 | 5875.8 | 5760.5 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 778.6 | 213.2 | 176.2 | 191.4 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 46.32 | 37.6 | -27.9 | 0.2 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 11.48 | 0 | 9 | 16.3 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 2.2 | |||||||||||||||||||||||
Deferred Revenue Non Current | 185.63 | 47 | 51.4 | 56.2 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 223.42 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 379.81 | 107.3 | 112.7 | 1.6 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 362.01 | 47.4 | 107.8 | 109.3 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 2.2 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 1621.95 | 420.7 | 396.6 | 434.2 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 4109.4 | 1027.3 | 1027.3 | 1027.3 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 16182.54 | 4077.8 | 3763.8 | 3632.1 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 2743.99 | 695.1 | 676.5 | 651.9 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0.86 | 0.4 | 0.4 | 0.1 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 23036.79 | 5800.6 | 5468.1 | 5311.5 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 24744.16 | 6277.8 | 5875.8 | 5760.5 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 38.37 | 9.4 | 11.2 | 14.7 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 23075.16 | 5810 | 5479.2 | 5326.2 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 24744.16 | - | - | - | |||||||||||||||||||||||
Total Investments | 7890.75 | 3036.4 | 1440.1 | 1403.6 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 75.19 | 37.6 | 0 | 2.5 | |||||||||||||||||||||||
balance-sheet.row.net-debt | -2692.08 | -646.2 | -595 | -825.4 |
Situația fluxurilor de numerar
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 284.9 | 228.3 | 421.3 | 361.5 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 6.41 | 113.9 | 99.8 | 89.5 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -6.3 | 14.4 | 25.6 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 6.3 | -14.4 | -25.6 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | 15.41 | 113.7 | 129.1 | 197.9 | ||||||||||||||||||||
cash-flows.row.account-receivables | 19.66 | 82.9 | 108.6 | 198.8 | ||||||||||||||||||||
cash-flows.row.inventory | -4.25 | 0.6 | -11.5 | -3.7 | ||||||||||||||||||||
cash-flows.row.account-payables | 0 | 36.6 | 17.5 | -22.7 | ||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -6.3 | 14.4 | 25.6 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 269.47 | -66.1 | -185.6 | -233.1 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 481.62 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -213.1 | -163.5 | -236.9 | -255.9 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | 0.01 | -3.4 | 16.5 | 0 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | -582.01 | -1247.4 | -1061 | -1517.2 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 487.59 | 896.1 | 1092.6 | 964.3 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | -71.42 | -22.2 | -9 | -33.3 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -383.53 | -540.4 | -197.8 | -842.1 | ||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -11 | -5.6 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -102.7 | -102.9 | -205.8 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 10.6 | 4.5 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -110.25 | -102.7 | -103.3 | -206.9 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.03 | 0.1 | 0 | 0.1 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | -153.55 | -253.2 | 163.5 | -633.1 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 2465.46 | 527.2 | 780.4 | 617 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 2619.01 | 780.4 | 617 | 1250.1 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | 481.62 | 389.8 | 464.6 | 415.8 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | -213.1 | -163.5 | -236.9 | -255.9 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | 268.53 | 226.3 | 227.7 | 159.9 |
Rândul din contul de profit și pierdere
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 962.21 | 1008.3 | 1050.2 | 1214.8 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 238.91 | 305.5 | 157 | 183.6 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 723.3 | 702.8 | 893.2 | 1031.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 166.1 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 19.27 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 214.73 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | -0.99 | -1 | 99.2 | 82.7 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 498.87 | 491.6 | 711.2 | 776.1 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 737.77 | 797.1 | 868.2 | 959.7 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 14.77 | 14.2 | 15.2 | 16.8 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0.1 | 0.1 | 0.2 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 214.73 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 53.63 | 241.5 | -4 | 0.3 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -0.99 | -1 | 99.2 | 82.7 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 53.63 | 241.5 | -4 | 0.3 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0.1 | 0.1 | 0.2 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 52.83 | 145.7 | 161 | 134.8 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 348.88 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 239.31 | 211.1 | 263.3 | 457.5 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 292.94 | 452.6 | 259.4 | 457.8 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 22.25 | 49.9 | 31 | 36.5 | |||||||||||||||||||||||
income-statement-row.row.net-income | 284.9 | 416.7 | 234.4 | 425.9 |
Întrebări frecvente
Ce este Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) totalul activelor?
Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) activele totale sunt 6277761845.000.
Care este venitul anual al întreprinderii?
Venitul anual este 482153895.000.
Care este marja de profit a întreprinderii?
Marja de profit a firmei este 0.752.
Care este fluxul de numerar liber al întreprinderii?
Fluxul de numerar liber este 0.261.
Care este marja de profit net a întreprinderii?
Marja profitului net este 0.296.
Care este venitul total al întreprinderii?
Venitul total este 0.249.
Care este Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) profitul net (venitul net)?
Profitul net (venitul net) este 416691942.000.
Care este datoria totală a firmei?
Datoria totală este 37593280.000.
Care este numărul cheltuielilor de exploatare?
Cheltuielile de exploatare sunt 491631884.000.
Care este cifra de numerar a firmei?
Numerarul întreprinderii este 643139595.000.